期刊文献+

厄贝沙坦联合左旋氨氯地平治疗高血压并发慢性肾功能不全的临床观察 被引量:2

Clinical observation of irbesartan combined with levamlodipine Levamlodipine treating hypertension complicated with chronic renal insufficiency
下载PDF
导出
摘要 目的观察厄贝沙坦联合左旋氨氯地平治疗高血压并发慢性肾功能不全的临床效果。方法将患者随机分为治疗组、对照组,治疗组服用厄贝沙坦联合左旋氨氯地平,对照组服用左旋氨氯地平,共治疗12周。定期检测患者的血压、血清钾、血尿酸、肝肾功能。结果两组治疗12周后的血压均明显下降(P<0.01),两组治疗后的收缩压差异有统计学意义(P<0.05),舒张压差异无统计学意义(P>0.05)。治疗组治疗后的尿蛋白明显下降(P<0.01),血尿酸也有所下降(P<0.05),与对照组比较,差异有统计学意义(P<0.05),其他生化指标无明显变化。结论厄贝沙坦联合左旋氨氯地平的效果好,副作用少,且对患者的肾功能有保护作用,是治疗慢性肾功能不全的理想药物。 Objective To observe the clinical effect of irbesartan combined with levamlodipine treating hypertension complicated with chronic renal insufficiency. Methods Patients were randomly divided into the treatment group and control group,the treatment group was treated with irbesartan combined with levamlodipine, and the control group was only given levamlodipine.Patients were treated for 12 weeks.Blood pressure,serum potassium,serum uric acid,liver and kidney function of patients were detected regularly. Results The blood pressure of the two groups after 12 weeks treatmerit decreased significantly (P〈0.01),and there was a statistical difference of the systolic blood pressure between the two groups (P〈0.05),there was no statistical difference of diastolic blood pressure between the two groups (P〉0.05).Compared with the control group,the urinary protein of the treatment group significantly decreased (P〈0.01),blood uric acid also decreased (P〈0.05),there was no obvious changes in other biochemical indexes. Conclusion Irbesartan combined with levamlodipine has a good effect with fewer side effects,and has protective role on renal function.Irbesartan combined with levamlodipine are idea drug treating chronic renal insufficiency.
作者 陈润唯
出处 《中国当代医药》 2015年第3期130-132,共3页 China Modern Medicine
关键词 厄贝沙坦 左旋氨氯地平 高血压 慢性肾功能不全 Irbesartan Levamlodipine Hypertension Chronic renal insufficiency
  • 相关文献

参考文献13

  • 1李昌松.厄贝沙坦联合左旋氨氯地平治疗原发性高血压的临床效果观察[J].中国当代医药,2014,21(1):109-110. 被引量:9
  • 2Sato W, Sato Y.Midkine in nephrogenesis, hypertension andkidney diseases[J].Br J Pharmacol,2014,171(4) :879-887.
  • 3Hartner A,Cordasic N,Klanke Byet al.Renal protection bylow dose irbesartan in diabetic nephropathy is paralleledby a reduction of inflammation,not of endoplasmic reticu-lum stress [J].Biochim Biophys Acta,2014,1842(4):558-.
  • 4Ayari H, Legedz L, Cerutti C,et al.Mutual amplification ofcorticosteroids and angiotensin systems in human vascularsmooth muscle cells and carotid atheromaPJJ Mol Med(Berl),2014.[Epub ahead of print].
  • 5Du N,Feng J,Hu LJyet al.Angiotensin II receptor type 1blockers suppress the cell proliferation effects of angiotensinII in breast cancer cells by inhibiting AT1R signaling[J].Oncol Rep,2012,27(6) :1893-1903.
  • 6Stang U,Mitchell LG.Fibrinogen[J].Methods Mol Biol ,2013,992:181-192.
  • 7Wlirzner G,Gerster JC’Chiolero A,et al.Comparative ef-fects of losartan and irbesartan on serum uric acid in hy-pertensive patients with hyperuricaemia and gout[J]J Hy-pertens, 2001 ,19(10);1855-1860.
  • 8何映琴,菅宏蕴.左旋氨氯地平与厄贝沙坦联合治疗糖尿病并发肾病临床分析[J].中国当代医药,2012,19(24):81-82. 被引量:4
  • 9Imanishi M,0kada N,Konishi Yfet a/Angiotensin II recep-tor blockade reduces salt sensitivity of blood pressurethrough restoration of renal nitric oxide synthesis in patientswith diabetic nephropathy[J]J Renin Angiotensin AldosteroneSyst,2012.[Epub ahead of print].
  • 10Jeffers BW’Bhambri R,Robbins J,et aL.Incremental bloodpressure 一lowering effect of titrating amlodipine for thetreatment of hypertension in patients including thoseaged ^55 years[J].Am J Ther,2014. [Epub ahead of print].

二级参考文献25

共引文献22

同被引文献21

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部